Centessa Long Term Debt vs Total Current Liabilities Analysis

CNTA Stock  USD 18.08  1.08  6.35%   
Centessa Pharmaceuticals financial indicator trend analysis is way more than just evaluating Centessa Pharmaceuticals prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Centessa Pharmaceuticals is a good investment. Please check the relationship between Centessa Pharmaceuticals Long Term Debt and its Total Current Liabilities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

Long Term Debt vs Total Current Liabilities

Long Term Debt vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Centessa Pharmaceuticals Long Term Debt account and Total Current Liabilities. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Centessa Pharmaceuticals' Long Term Debt and Total Current Liabilities is 0.87. Overlapping area represents the amount of variation of Long Term Debt that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Centessa Pharmaceuticals PLC, assuming nothing else is changed. The correlation between historical values of Centessa Pharmaceuticals' Long Term Debt and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Long Term Debt of Centessa Pharmaceuticals PLC are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Long Term Debt i.e., Centessa Pharmaceuticals' Long Term Debt and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.87
Relationship DirectionPositive 
Relationship StrengthStrong

Long Term Debt

Long-term debt is a debt that Centessa Pharmaceuticals has held for over one year. Long-term debt appears on Centessa Pharmaceuticals PLC balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Centessa Pharmaceuticals PLC balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Total Current Liabilities

Total Current Liabilities is an item on Centessa Pharmaceuticals balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Centessa Pharmaceuticals PLC are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Centessa Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Centessa Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
At present, Centessa Pharmaceuticals' Issuance Of Capital Stock is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 758.2 M, whereas Selling General Administrative is forecasted to decline to about 33.9 M.
 2021 2023 2024 (projected)
Depreciation And Amortization34.0K813.1K853.8K
Interest Income244K10.5M11.0M

Centessa Pharmaceuticals fundamental ratios Correlations

0.950.881.0-0.830.80.990.360.50.950.971.00.790.880.99-0.39-0.880.890.940.910.80.810.99-0.76-0.391.0
0.950.970.93-0.940.840.920.410.681.00.990.940.850.980.98-0.51-0.720.960.810.980.680.940.95-0.66-0.510.95
0.880.970.84-0.960.870.830.510.710.980.950.860.880.990.92-0.53-0.620.990.710.990.670.970.88-0.67-0.530.89
1.00.930.84-0.80.761.00.30.450.930.941.00.740.850.97-0.35-0.910.860.960.880.820.770.99-0.78-0.350.99
-0.83-0.94-0.96-0.8-0.79-0.78-0.46-0.86-0.94-0.91-0.81-0.77-0.98-0.90.740.49-0.96-0.61-0.97-0.51-0.97-0.860.510.74-0.86
0.80.840.870.76-0.790.770.830.580.830.90.790.990.810.83-0.46-0.610.80.690.820.580.780.81-0.56-0.460.81
0.990.920.831.0-0.780.770.340.430.920.941.00.750.830.96-0.33-0.920.840.960.870.830.740.99-0.79-0.330.99
0.360.410.510.3-0.460.830.340.420.40.520.350.790.420.4-0.4-0.210.420.260.420.20.410.4-0.2-0.40.39
0.50.680.710.45-0.860.580.430.420.660.640.480.530.760.63-0.94-0.040.70.180.720.010.830.55-0.01-0.940.55
0.951.00.980.93-0.940.830.920.40.660.980.940.840.980.98-0.49-0.730.970.810.990.720.940.95-0.7-0.490.95
0.970.990.950.94-0.910.90.940.520.640.980.960.90.940.99-0.5-0.760.930.840.950.70.90.96-0.66-0.50.97
1.00.940.861.0-0.810.791.00.350.480.940.960.780.870.98-0.37-0.890.870.950.890.80.780.99-0.76-0.370.99
0.790.850.880.74-0.770.990.750.790.530.840.90.780.820.82-0.36-0.620.80.690.820.60.790.78-0.58-0.360.79
0.880.980.990.85-0.980.810.830.420.760.980.940.870.820.93-0.6-0.590.990.71.00.630.980.89-0.62-0.60.89
0.990.980.920.97-0.90.830.960.40.630.980.990.980.820.93-0.49-0.80.920.870.940.710.880.98-0.67-0.490.99
-0.39-0.51-0.53-0.350.74-0.46-0.33-0.4-0.94-0.49-0.5-0.37-0.36-0.6-0.49-0.05-0.55-0.08-0.560.1-0.64-0.46-0.11.0-0.45
-0.88-0.72-0.62-0.910.49-0.61-0.92-0.21-0.04-0.73-0.76-0.89-0.62-0.59-0.8-0.05-0.63-0.99-0.65-0.92-0.47-0.850.87-0.05-0.85
0.890.960.990.86-0.960.80.840.420.70.970.930.870.80.990.92-0.55-0.630.731.00.70.960.9-0.71-0.550.9
0.940.810.710.96-0.610.690.960.260.180.810.840.950.690.70.87-0.08-0.990.730.750.910.580.92-0.87-0.080.92
0.910.980.990.88-0.970.820.870.420.720.990.950.890.821.00.94-0.56-0.651.00.750.690.960.92-0.69-0.560.92
0.80.680.670.82-0.510.580.830.20.010.720.70.80.60.630.710.1-0.920.70.910.690.50.78-0.990.10.78
0.810.940.970.77-0.970.780.740.410.830.940.90.780.790.980.88-0.64-0.470.960.580.960.50.81-0.5-0.640.82
0.990.950.880.99-0.860.810.990.40.550.950.960.990.780.890.98-0.46-0.850.90.920.920.780.81-0.74-0.461.0
-0.76-0.66-0.67-0.780.51-0.56-0.79-0.2-0.01-0.7-0.66-0.76-0.58-0.62-0.67-0.10.87-0.71-0.87-0.69-0.99-0.5-0.74-0.1-0.74
-0.39-0.51-0.53-0.350.74-0.46-0.33-0.4-0.94-0.49-0.5-0.37-0.36-0.6-0.491.0-0.05-0.55-0.08-0.560.1-0.64-0.46-0.1-0.45
1.00.950.890.99-0.860.810.990.390.550.950.970.990.790.890.99-0.45-0.850.90.920.920.780.821.0-0.74-0.45
Click cells to compare fundamentals

Centessa Pharmaceuticals Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Centessa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Centessa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Centessa Pharmaceuticals Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Centessa Pharmaceuticals Plc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Centessa Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Centessa Pharmaceuticals. If investors know Centessa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Centessa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.55)
Revenue Per Share
0.068
Return On Assets
(0.25)
Return On Equity
(0.56)
The market value of Centessa Pharmaceuticals is measured differently than its book value, which is the value of Centessa that is recorded on the company's balance sheet. Investors also form their own opinion of Centessa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Centessa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Centessa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Centessa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Centessa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Centessa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Centessa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.